145 related articles for article (PubMed ID: 2110840)
1. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine.
Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
Blood; 1990 May; 75(10):1999-2004. PubMed ID: 2110840
[TBL] [Abstract][Full Text] [Related]
2. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
[TBL] [Abstract][Full Text] [Related]
3. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.
Scandella D; Gilbert GE; Shima M; Nakai H; Eagleson C; Felch M; Prescott R; Rajalakshmi KJ; Hoyer LW; Saenko E
Blood; 1995 Sep; 86(5):1811-9. PubMed ID: 7544643
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor.
Saenko EL; Scandella D
J Biol Chem; 1995 Jun; 270(23):13826-33. PubMed ID: 7775440
[TBL] [Abstract][Full Text] [Related]
5. Membrane-binding properties of the Factor VIII C2 domain.
Novakovic VA; Cullinan DB; Wakabayashi H; Fay PJ; Baleja JD; Gilbert GE
Biochem J; 2011 Apr; 435(1):187-96. PubMed ID: 21210768
[TBL] [Abstract][Full Text] [Related]
6. A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factor.
Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
Thromb Haemost; 1990 Jun; 63(3):403-6. PubMed ID: 2119526
[TBL] [Abstract][Full Text] [Related]
7. Role of factor VIII C2 domain in factor VIII binding to factor Xa.
Nogami K; Shima M; Hosokawa K; Suzuki T; Koide T; Saenko EL; Scandella D; Shibata M; Kamisue S; Tanaka I; Yoshioka A
J Biol Chem; 1999 Oct; 274(43):31000-7. PubMed ID: 10521497
[TBL] [Abstract][Full Text] [Related]
8. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.
Ortel TL; Devore-Carter D; Quinn-Allen M; Kane WH
J Biol Chem; 1992 Feb; 267(6):4189-98. PubMed ID: 1740460
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant effects of a synthetic peptide containing residues Thr-2253-Gln-2270 within factor VIII C2 domain that selectively inhibits factor Xa-catalysed factor VIII activation.
Nogami K; Shima M; Nishiya K; Hosokawa K; Saenko EL; Giddings JC; Tanaka I; Yoshioka A
Br J Haematol; 2002 Mar; 116(4):868-74. PubMed ID: 11886394
[TBL] [Abstract][Full Text] [Related]
10. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
[TBL] [Abstract][Full Text] [Related]
11. Amphipathic helices support function of blood coagulation factor IXa.
Blostein MD; Rigby AC; Furie BC; Furie B; Gilbert GE
Biochemistry; 2000 Oct; 39(39):12000-6. PubMed ID: 11009614
[TBL] [Abstract][Full Text] [Related]
12. The preparation and phospholipid binding property of the C2 domain of human factor VIII.
Takeshima K; Smith C; Tait J; Fujikawa K
Thromb Haemost; 2003 May; 89(5):788-94. PubMed ID: 12719774
[TBL] [Abstract][Full Text] [Related]
13. Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
Barrow RT; Healey JF; Jacquemin MG; Saint-Remy JM; Lollar P
Blood; 2001 Jan; 97(1):169-74. PubMed ID: 11133757
[TBL] [Abstract][Full Text] [Related]
14. Binding of factor VIII inhibitors to discrete regions of the factor VIII C2 domain disrupt phospholipid binding.
Lewis DA; Moore KD; Ortel TL
Blood Coagul Fibrinolysis; 2003 Jun; 14(4):361-8. PubMed ID: 12945878
[TBL] [Abstract][Full Text] [Related]
15. Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effect.
Nogami K; Shima M; Nakai H; Tanaka I; Suzuki H; Morichika S; Shibata M; Saenko EL; Scandella D; Giddings JC; Yoshioka A
Br J Haematol; 1999 Oct; 107(1):196-203. PubMed ID: 10520041
[TBL] [Abstract][Full Text] [Related]
16. A murine monoclonal anti-factor VIII inhibitory antibody and two human factor VIII inhibitors bind to different areas within a twenty amino acid segment of the acidic region of factor VIII heavy chain.
Foster PA; Fulcher CA; Houghten RA; de Graaf Mahoney S; Zimmerman TS
Blood Coagul Fibrinolysis; 1990; 1(1):9-15. PubMed ID: 2129392
[TBL] [Abstract][Full Text] [Related]
17. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
[TBL] [Abstract][Full Text] [Related]
18. An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor.
Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
J Biol Chem; 1988 Apr; 263(11):5230-4. PubMed ID: 2895765
[TBL] [Abstract][Full Text] [Related]
19. Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain.
Foster PA; Fulcher CA; Houghten RA; de Graaf Mahoney S; Zimmerman TS
J Clin Invest; 1988 Jul; 82(1):123-8. PubMed ID: 2839543
[TBL] [Abstract][Full Text] [Related]
20. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
Nogami K; Shima M; Nishiya K; Sakurai Y; Tanaka I; Giddings JC; Saenko EL; Yoshioka A
Thromb Haemost; 2002 Mar; 87(3):459-65. PubMed ID: 11916079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
